• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COCHLEAR LIMITED COCHLEAR OSIA OSI200 IMPLANT; NUCLEUS 24 COCHLEAR IMPLANT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COCHLEAR LIMITED COCHLEAR OSIA OSI200 IMPLANT; NUCLEUS 24 COCHLEAR IMPLANT SYSTEM Back to Search Results
Model Number OSI200
Device Problem Expulsion (2933)
Patient Problems Wound Dehiscence (1154); Cellulitis (1768); Post Operative Wound Infection (2446)
Event Type  Injury  
Event Description
Per the clinic, the patient developed a wound infection (cellulitis) at the incision site leading to wound dehiscence and exposure of the receiver/stimulator.There are plans to explant the device; however, this has not occurred as of the date of this report.Additional information has been requested but has not been made available as of the date of this report.
 
Manufacturer Narrative
This report is submitted on january 04, 2023.
 
Manufacturer Narrative
Per the clinic, it was also reported that the patient underwent attempted revision surgery (date not reported).However, the issue could not be resolved.The device was explanted on (b)(6) 2023.There are plans to reimplant the patient with a new device; however, this has not occurred as of the date of this report.This report is submitted on january 26, 2024.
 
Manufacturer Narrative
Correction: the correct b4 for mdr folow-up #2 is (b)(6) 2024.This report is submitted on (b)(6) 2024.
 
Manufacturer Narrative
Per the clinic, the patient was placed on a 28 days course of topical antibiotics (specific date not reported).Device analysis report attached.This report is submitted on february 27, 2024.
 
Manufacturer Narrative
Per the clinic, it was reported that the patient underwent revision surgery on (b)(6) 2024 under general anaesthetic.This report is submitted on april 17, 2024.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COCHLEAR OSIA OSI200 IMPLANT
Type of Device
NUCLEUS 24 COCHLEAR IMPLANT SYSTEM
Manufacturer (Section D)
COCHLEAR LIMITED
1 university avenue
macquarie university
nsw 2109
AS  2109
Manufacturer (Section G)
COCHLEAR LTD
1 university avenue
macquarie university, nsw 2109
AS   2109
Manufacturer Contact
hakim muhaimin jamil
unit ug-1, vertical podium
no. 8 jalan kerinchi
kuala lumpur, wilayah persekutuan 59200
MY   59200
MDR Report Key18441568
MDR Text Key331858411
Report Number6000034-2024-00054
Device Sequence Number1
Product Code MCM
UDI-Device Identifier09321502046152
UDI-Public(01)09321502046152(11)230803(17)250802
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190589
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 03/12/2024
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received01/04/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberOSI200
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Date Manufacturer Received03/12/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/03/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-